Similar articles

• Antiblastic drug targeting to hepatocellular carcinoma cells: a potential therapeutic improvement?

  Merle P, Trepo C. Merle P, et al. Ital J Gastroenterol Hepatol. 1998 Apr;30(2):178-80. Ital J Gastroenterol Hepatol. 1998. PMID: 9675654 Review. No abstract available.
• Effect of ethanol on asialoglycoprotein receptor function.

  Casey CA, Sorrell MF, Tuma DJ. Casey CA, et al. Targeted Diagn Ther. 1991;4:189-213. Targeted Diagn Ther. 1991. PMID: 1665719 Review. No abstract available.
• [Can adjuvant chemotherapy of hepatocellular carcinoma improve results of liver transplantation?].

  Burtin P. Burtin P. Gastroenterol Clin Biol. 1993;17(10):776-7. Gastroenterol Clin Biol. 1993. PMID: 8288099 French. No abstract available.
• [Selective chemotherapy of hepatocellular carcinomas].

  Keppler D, Pausch J, Gerok W. Keppler D, et al. Verh Dtsch Ges Inn Med. 1978;(84):606-10. Verh Dtsch Ges Inn Med. 1978. PMID: 217196 Review. German. No abstract available.
• Chemotherapy for advanced hepatocellular carcinoma: systemic chemotherapy or hepatic arterial infusion chemotherapy?

  Yamashita T. Yamashita T. J Gastroenterol. 2004;39(4):404-6. doi: 10.1007/s00535-004-1330-0. J Gastroenterol. 2004. PMID: 15168258 No abstract available.